Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Precision Health Database


Genomics & Health Impact Scan Database|Search|PHGKB

Cancer

Last data update: Apr 01, 2023. (Total: 59043 Documents since 2012)
   dataset      
Filtered By:

Previous    

Records 1 - 21 (of 21 Records)

Query Trace: Prostate Cancer[original query]>>Guidelines Related[Product Type]
Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies.
Russo A et al. ESMO open 2022 7(3) 100459
Update Swiss guideline for counselling and testing for predisposition to breast, ovarian, pancreatic and prostate cancer.
Stoll Susanna et al. Swiss medical weekly 2021 151w30038
Recent Insights on Genetic Testing in Primary Prostate Cancer.
Kafka Mona et al. Molecular diagnosis & therapy 2021
Practical Considerations and Challenges for Germline Genetic Testing in Patients With Prostate Cancer: Recommendations From the Germline Genetics Working Group of the PCCTC.
Szymaniak Brittany M et al. JCO oncology practice 2020 Sep OP2000431
Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.
Giri Veda N et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020 Jun JCO2000046
Current recommendations for prostate cancer genetic testing: NCCN prostate guideline.
Mohler James L et al. The Canadian journal of urology 2019 Oct 26(5S2) 34-37
Prostate cancer genetic testing: NCCN familial high-risk assessment: breast/ovarian.
Daly Mary B et al. The Canadian journal of urology 2019 Oct 26(5S2) 29-30
Contemporary prognostic indicators for prostate cancer incorporating International Society of Urological Pathology recommendations.
Egevad Lars et al. Pathology 2018 Jan 50(1) 60-73
Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer.
Sumanasuriya Semini et al. European urology oncology 2018 1(2) 151-159
Local Coverage Determination (LCD): Genetic Testing for Lynch Syndrome (L34912)
The U.S. Centers for Medicare & Medicaid Services
Local Coverage Determination (LCD): BRCA1 and BRCA2 Genetic Testing (L36715)
The U.S. Centers for Medicare & Medicaid Services
Local Coverage Determination (LCD): BRCA1 and BRCA2 Genetic Testing (L36499)
The U.S. Centers for Medicare & Medicaid Services
Local Coverage Determination (LCD): Biomarker Testing (Prior to Initial Biopsy) for Prostate Cancer Diagnosis (L37733)
The U.S. Centers for Medicare & Medicaid Services
Local Coverage Determination (LCD): Biomarker Testing for Neuroendocrine Tumors/Neoplasms (L37851)
The U.S. Centers for Medicare & Medicaid Services
NCCN Guidelines Updates: Management of Prostate Cancer.
Mohler James L et al. Journal of the National Comprehensive Cancer Network : JNCCN 2019 May 17(5.5) 583-586
NCCN Prostate Cancer Update Emphasizes Germline Testing,
by Mary Caffrey, AJMC, March 22, 2019
Providing clinicians and patients with important information to help guide decisions about prostate cancer screening.
USPSTF, October 8, 2018
NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection.
Carroll Peter H et al. Journal of the National Comprehensive Cancer Network : JNCCN 2018 May 16(5S) 620-623
Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
, et al. JAMA 2018 0 0. (18) 1901-1913
NCCN Updates Prostate Cancer Management Guidelines,
Journal of Clinical Pathways, February 23, 2018
Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.
Giri Veda N et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 Dec JCO2017741173
TOP